tiprankstipranks
Advertisement
Advertisement
Unicycive Therapeutics receives complete response letter from FDA for OLC NDA
PremiumThe FlyUnicycive Therapeutics receives complete response letter from FDA for OLC NDA
1d ago
H.C. Wainwright recommends taking advantage of Unicycive stock weakness
Premium
The Fly
H.C. Wainwright recommends taking advantage of Unicycive stock weakness
5d ago
Unicycive Expands At-The-Market Equity Offering Program
Premium
Company Announcements
Unicycive Expands At-The-Market Equity Offering Program
26d ago
Unicycive Therapeutics price target lowered to $37 from $40 at Guggenheim
PremiumThe FlyUnicycive Therapeutics price target lowered to $37 from $40 at Guggenheim
2M ago
Unicycive Therapeutics reports Q1 EPS (50c), consensus (47c)
Premium
The Fly
Unicycive Therapeutics reports Q1 EPS (50c), consensus (47c)
2M ago
Unicycive Therapeutics initiated with a Buy at B. Riley
Premium
The Fly
Unicycive Therapeutics initiated with a Buy at B. Riley
2M ago
Positioning Oxylanthanum Carbonate for Category-Defining Growth via TDAPA Advantage, Regulatory Clarity, and Robust Shareholder Returns
PremiumRatingsPositioning Oxylanthanum Carbonate for Category-Defining Growth via TDAPA Advantage, Regulatory Clarity, and Robust Shareholder Returns
4M ago
Unicycive Therapeutics management to meet with Piper Sandler
Premium
The Fly
Unicycive Therapeutics management to meet with Piper Sandler
4M ago
Unicycive Therapeutics initiated with a Buy at WestPark Capital
Premium
The Fly
Unicycive Therapeutics initiated with a Buy at WestPark Capital
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100